Jasmine Lee

Experts / Jasmine Lee

Jasmine Lee is a pharmacist, and PhD candidate at the University of Sydney.

Can the hair-loss drug finasteride affect mental health?

Here's what the evidence says about the risks...

Obstetrics and gynaecology, Women's health

Clinical Articles

Ryeqo approved for endometriosis

Ryeqo has been available in Australia since 2022, but until now was not specifically indicated for endometriosis. Here's how it works and what you need to be aware of.

Ryeqo approved for endometriosis

Ryeqo has been available in Australia since 2022, but until now was not specifically indicated for endometriosis. Here's how it works and what you need to be aware of.

By A/Prof Nial Wheate, Jasmine Lee

Clinical Articles

Obstetrics and gynaecology, Women's health

Can the hair-loss drug finasteride affect mental health?

Here's what the evidence says about the risks...

By Prof Nial Wheate, Jasmine Lee

Clinical Articles

Drugs and devices

Jasmine Lee

More from this expert

Can the hair-loss drug finasteride affect mental health?

Here's what the evidence says about the risks...

Ryeqo approved for endometriosis

Ryeqo has been available in Australia since 2022, but until now was not specifically indicated for endometriosis. Here's how it works and what you need to be aware of.

Ryeqo approved for endometriosis

Ryeqo has been available in Australia since 2022, but until now was not specifically indicated for endometriosis. Here's how it works and what you need to be aware of.

Can the hair-loss drug finasteride affect mental health?

Here's what the evidence says about the risks...

Get the app

Site

Company

Connect

Legal

Discover

Healthed

Upcoming Healthed Webcast

Premature Ovarian Insufficiency – The New Guidelines

Tuesday 3rd March, 7pm - 9pm AEDT

Speaker

Prof Rodney Baber AM

Obstetrician and Gynaecologist; Clinical Professor, University of Sydney

Join Prof Rodney Baber AM for this presentation where he will discuss the new guidelines related to POI and the most relevant recommendations that will affect clinical practice and assist in better recognition, understanding, diagnosis and management.

Jasmine Lee

More from this expert

Can the hair-loss drug finasteride affect mental health?

Here's what the evidence says about the risks...

Ryeqo approved for endometriosis

Ryeqo has been available in Australia since 2022, but until now was not specifically indicated for endometriosis. Here's how it works and what you need to be aware of.

Ryeqo approved for endometriosis

Ryeqo has been available in Australia since 2022, but until now was not specifically indicated for endometriosis. Here's how it works and what you need to be aware of.

Can the hair-loss drug finasteride affect mental health?

Here's what the evidence says about the risks...

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Sign up for a free Healthed account

Extra Details

PASSWORD RESET

Discover

Healthed

Upcoming Healthed Webcast

Premature Ovarian Insufficiency – The New Guidelines

Tuesday 3rd March, 7pm - 9pm AEDT

Speaker

Prof Rodney Baber AM

Obstetrician and Gynaecologist; Clinical Professor, University of Sydney

Join Prof Rodney Baber AM for this presentation where he will discuss the new guidelines related to POI and the most relevant recommendations that will affect clinical practice and assist in better recognition, understanding, diagnosis and management.